Focused Jurisdictional Scan of Glomerulonephritis Medication Access in Canada: A Program Report.

Rohini NaipaulCatherine MarquesJenny NgSean BarbourClifford LoAinslie M HildebrandValerie SiuBhanu PrasadLouis-Philippe LaurinLori D WaznySean ArmstrongJaclyn TranManeka SheffieldArenn Jauhal Michelle A Hladunewich

Published in: Canadian journal of kidney health and disease (2023)

While patients in most provinces have similar needs and nephrologists similar prescribing patterns, gaps still exist for publicly funded GN medications. Interprovincial differences in the drugs funded, funding criteria, and application process may affect timely and equitable access to GN medications across Canada. Given the rarity of GN, a pan-Canadian funding approach may be warranted to improve the current state.

Keyphrases

end stage renal disease
ejection fraction
primary care
newly diagnosed
computed tomography
healthcare
peritoneal dialysis
adverse drug
quality improvement
patient reported outcomes
drug induced